Gut Microbiome Diversity Lower in Chronic Pelvic Pain Syndrome

This article originally appeared here.
Share this content:
Gut Microbiome Diversity Lower in Chronic Pelvic Pain Syndrome
Gut Microbiome Diversity Lower in Chronic Pelvic Pain Syndrome

MONDAY, July 25, 2016 (HealthDay News) -- Gut microbiome diversity is significantly lower in patients with chronic pelvic pain syndrome, with wider clustering, according to a study published in the August issue of The Journal of Urology.

Daniel A. Shoskes, M.D., from the Glickman Urological Institute in Cleveland, and colleagues examined the gut microbiome in patients with chronic pelvic pain syndrome and controls who were asymptomatic or only had urinary tract symptoms. Total DNA was extracted from samples and bacterial specific 16S rRNA capture was performed. Complete data were available for 25 patients and 25 controls.

The researchers identified tighter clustering of controls in a space distinct from the wider clustering of cases in three-dimensional UniFrac principal coordinate analysis (P = 0.001); cases had decreased alpha diversity (P = 0.001). Three taxa were overrepresented in cases and 12 were underrepresented (including Prevotella) compared with controls.

"Patients with chronic pelvic pain syndrome have significantly less gut microbiome diversity which clusters differently from controls, and robustly lower counts of Prevotella, with separation sufficient to serve as a potential biomarker," the authors write. "The gut microbiome may serve as disease biomarker and potential therapeutic target in chronic pelvic pain syndrome."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »